PedAM
Pediatric Disease Annotations & Medicines
| Disease | cardiogenic shock |
| Phenotype | |myocardial infarction |
| Sentences | 154 |
| PubMedID- 22767014 | The successful combined use of impella lp 2.5 and intra-aortic balloon pump in st-elevation myocardial infarction with refractory cardiogenic shock. |
| PubMedID- 24848410 | Recent findings: recently published randomized controlled trials (rcts) and meta-analyses have demonstrated acceptable safety for iabp but have raised doubt over efficacy in acute myocardial infarction (mi) both with and without cardiogenic shock. |
| PubMedID- 20606428 | Comparison of 30-day mortality between anterior-wall versus inferior-wall st-segment elevation myocardial infarction complicated by cardiogenic shock in patients undergoing primary coronary angioplasty. |
| PubMedID- 23265097 | Background: sex differences in the management of acute myocardial infarction (ami) patients with cardiogenic shock (cs) have not been well studied. |
| PubMedID- 26054832 | Device therapy: where next in cardiogenic shock owing to myocardial infarction. |
| PubMedID- 22920912 | Intraaortic balloon support for myocardial infarction with cardiogenic shock. |
| PubMedID- 23613700 | Suspicious of non st-segment elevation myocardial infarction combined with cardiogenic shock, we performed coronary angiography. |
| PubMedID- 24133507 | Though there were three (8.8%) in-hospital deaths in our patients, none were procedure-related and all were caused by underlying extensive myocardial infarction with cardiogenic shock. |
| PubMedID- 23293180 | Acute intraventricular thrombosis of an impella lp 5.0 device in an st-elevated myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23147461 | Drug-eluting stents should not be used in st-elevated myocardial infarction with cardiogenic shock. |
| PubMedID- 25822657 | Importance: intra-aortic balloon pump (iabp) therapy is a widely used intervention for acute myocardial infarction with cardiogenic shock. |
| PubMedID- 25528363 | Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |
| PubMedID- 26373810 | Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: evidence from the portuguese nationwide registry. |
| PubMedID- 22572491 | Background: mortality in acute myocardial infarction (ami) complicated by cardiogenic shock (cs) approaches 70 - 80%, regardless of the type of pharmacological treatment. |
| PubMedID- 25183544 | There is limited clinical data comparing different p2y12-receptor inhibitors in patients with acute myocardial infarction (ami) complicated by cardiogenic shock. |
| PubMedID- 25855797 | Culprit or multivessel revascularisation in st-elevation myocardial infarction with cardiogenic shock. |
| PubMedID- 20690098 | Intra-aortic balloon pumps (iabp) are commonly used in the setting of an acute myocardial infarction that is complicated by cardiogenic shock or mechanical complications such as a ventricular septal defect or papillary muscle rupture. |
| PubMedID- 22913597 | Acute left main occlusion is a rare but devastating presentation of myocardial infarction, invariably with cardiogenic shock. |
| PubMedID- 22121422 | We diagnosed acute anterior myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 25689547 | Objectives: to investigate the outcome of patients with acute myocardial infarction (ami) complicated by refractory cardiogenic shock (cs) who underwent mechanical circulatory support with impella 2.5. |
| PubMedID- 20515862 | A 60-year-old man was admitted to our department with non st-segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 22847042 | Efficacy and timing of intra-aortic counterpulsation in patients with st-elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 22864324 | [acute anterior myocardial infarction presented with cardiogenic shock in a patient on herbal medication]. |
| PubMedID- 22236463 | Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the ehs-pci registry). |
| PubMedID- 24011548 | Interpretation: in patients undergoing early revascularisation for myocardial infarction complicated by cardiogenic shock, iabp did not reduce 12 month all-cause mortality. |
| PubMedID- 20648428 | Blood glucose level on admission determines in-hospital and long-term mortality in patients with st-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. |
| PubMedID- 24385385 | Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. |
| PubMedID- 25984680 | However, current literature demonstrated significantly varied indications for iabp application and prognosis.the objective of the study was to assess the potential benefits or risks of iabp treatment for acute myocardial infarction (ami) complicated with or without cardiogenic shock.medline and embase database were systematically searched until november 2014, using the terms as follows: iabp, iabc (intra-aortic balloon counterpulsation), ami, heart infarction, coronary artery disease, ischemic heart disease, and acute coronary syndrome. |
| PubMedID- 26148217 | Initiation of an algorithm-based ecmo program improved the outcomes in patients with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 25976448 | However, its impact on on-treatment platelet reactivity and clinical outcome in patients with acute myocardial infarction (ami) complicated by cardiogenic shock and undergoing pci with p2y12 receptor inhibitor treatment is less clear. |
| PubMedID- 21130711 | Although the use of percutaneous circulatory assist devices is gaining increasing acceptance as an adjunct to percutaneous coronary intervention (pci) in patients with cardiogenic shock, their role in patients with acute myocardial infarction (mi) without hemodynamic compromise and elective high-risk pci remains controversial. |
| PubMedID- 26288729 | Based on the clinical findings, ecg changes and transthoracic echo findings, acute transmural posterior wall myocardial infarction with cardiogenic shock was assumed to be the cause of circulatory arrest. |
| PubMedID- 25489303 | Impact of intra-aortic balloon pump on long-term mortality of unselected patients with st-segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 22671583 | Little is known about the antiplatelet action of the thienopyridines, clopidogrel and prasugrel, as well as the non-thienopyridine, ticagrelor, in patients suffering from st-elevation myocardial infarction (stemi) complicated by cardiogenic shock since systematic comparisons of these antiplatelet agents in this devastating condition are limited so far. |
| PubMedID- 19108906 | We report a case of emergent percutaneous intervention to a cabrol graft-left main anastomosis in a patient who presented with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 19789449 | Objective: to evaluate the clinical and prognostic relevance of acute kidney injury (aki) in the setting of st-elevation acute myocardial infarction (stemi) complicated by cardiogenic shock (cs). |
| PubMedID- 25637294 | Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the iabp-shock ii-trial. |
| PubMedID- 25830921 | Unverzagt s, machemermt, solms a, thiele h, burkhoff d, seyfarthm, dewaha a, ohman em, buerke m, haerting j, werdan k, prondzinsky r. intra-aortic balloon pump counterpulsation (iabp) for myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23453102 | Background: although radial approach is increasingly used in percutaneous coronary interventions (pcis) including in acute myocardial infarction (mi), patients with cardiogenic shock have been excluded from comparisons with femoral approach. |
| PubMedID- 26048389 | Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 21602670 | Methods: from january 2004 through august 2010, a total of 34 st-elevation myocardial infarction patients with profound cardiogenic shock were admitted to our intensive care unit and treated with either the impella 2.5 or the impella 5.0 device. |
| PubMedID- 19033082 | We sought to assess the clinical efficacy of thrombus aspiration during primary percutaneous coronary interventions (pci) in patients presenting with st-elevation myocardial infarction (stemi) complicated by cardiogenic shock (cs). |
| PubMedID- 24090250 | Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain st segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 25136881 | Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the alkk-pci registry. |
| PubMedID- 22431494 | Patients in a variety of cardiovascular disease states may benefit from temporary percutaneous cardiac support, including those in acute decompensated heart failure, fulminant myocarditis, acute myocardial infarction with or without cardiogenic shock and those undergoing high-risk percutaneous coronary intervention. |
| PubMedID- 23468450 | A 34-year-old male patient was referred for primary percutaneous coronary intervention for st-segment elevation myocardial infarction with cardiogenic shock and was found to have embolic left coronary artery occlusion and subsegmental pulmonary artery emboli as a consequence of venous thrombosis to trauma to the thigh in the presence of a patent foramen ovale. |
| PubMedID- 23995129 | Furthermore, a large scale randomized trial found no benefit on 30-day mortality in patients with myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23831043 | [acute myocardial infarction complicated by cardiogenic shock: what changed over a 10-year time span. |
| PubMedID- 24170231 | Background: recent evidence questions the role of intra-aortic balloon counterpulsation (iabp) in the treatment of acute myocardial infarction (ami) complicated by cardiogenic shock (cs). |
| PubMedID- 21849830 | myocardial infarction complicated by cardiogenic shock: a possible role for the impella device. |